6 Jul 2005

UCB sells its food diagnostics business to Neogen

Read More
29 Jun 2005

Positive opinion for UCB's Xyrem® for the treatment of cataplexy in adults with narcolepsy

Read More
24 Jun 2005

FDA Approves UCB's Keppra® for Use in Childhood Epilepsy

Read More
14 Jun 2005

UCB Confirms Positive Financial Outlook for 2005

Read More
13 May 2005

UCB and Lonza Enter Into a Strategic Bio-Manufacturing Alliance

Read More
19 Apr 2005

UCB Confirms Strong Quarterly Sales In The Us Xyzal Sells More Than Zyrtec In Europe

Read More
18 Apr 2005

UCB Announces European Launch Of Kentera(TM) The First European Transdermal Oxybutynin Treatment For Overactive Bladder

Read More
31 Mar 2005

First evidence of efficacy for UCB's Keppra®* in the adjunctive treatment of myoclonic seizures

Read More
23 Mar 2005

UCB Group confirms its previously announced 2004 results and provides IFRS reconciliation and product update

Read More
1 Mar 2005

UCB: Closing Of The Sale Of Its Surface Specialties Division

Read More
Subscribe to